BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6608600)

  • 1. [A case of von Willebrand's disease--successful application of 1-deamino-8-D-arginine vasopressin (DDAVP) to ovarian bleeding].
    Shiraishi K; Ebata H; Sato K; Tanaka M; Nouno R; Mashiko N; Yamaguchi G; Kubo Y; Tanikawa K; Ide K
    Rinsho Ketsueki; 1983 Dec; 24(12):1674-9. PubMed ID: 6608600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
    Kobayashi I; Takahashi H; Sanada M; Takahashi K; Hattori A; Ito M; Sakuragawa N; Shibata A; Shinada S; Tsukada T
    Rinsho Ketsueki; 1979 Apr; 20(4):364-71. PubMed ID: 312954
    [No Abstract]   [Full Text] [Related]  

  • 3. Mild bleeding disorders: review of 120 patients.
    Bolton-Maggs P; Wilkinson LS
    Clin Lab Haematol; 1984; 6(3):247-56. PubMed ID: 6335071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease].
    Streit A; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1389-91. PubMed ID: 6333722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.
    Ockelford PA; Menon NC; Berry EW
    N Z Med J; 1980 Nov; 92(672):375-8. PubMed ID: 6970907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of DDAVP for management of surgical hemorrhage from a Doberman pinscher with von Willebrand's disease.
    Kraus KH; Turrentine MA; Johnson GS
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):276. PubMed ID: 3258698
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hemophilia A and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP].
    Ingerslev J; Christiansen SE; Kristensen T; Wallevik K; Bernvil SS
    Ugeskr Laeger; 1985 Nov; 147(45):3592-4. PubMed ID: 3907076
    [No Abstract]   [Full Text] [Related]  

  • 9. DDAVP in haemophilia and von Willebrand's disease.
    Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
    Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
    Takahashi H
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
    [No Abstract]   [Full Text] [Related]  

  • 13. Desamino-D-arginine vasopressin and bleeding time in von Willebrand's disease.
    Isola L; Forster A; Aledort LM
    Ann Intern Med; 1984 Nov; 101(5):719-20. PubMed ID: 6435493
    [No Abstract]   [Full Text] [Related]  

  • 14. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
    Theiss W; Schmidt G
    Thromb Res; 1978 Dec; 13(6):1119-23. PubMed ID: 311959
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative management of patients with von Willebrand's disease.
    Cameron CB; Kobrinsky N
    Can J Anaesth; 1990 Apr; 37(3):341-7. PubMed ID: 2182206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease.
    Menon C; Berry EW; Ockelford P
    Lancet; 1978 Sep; 2(8092 Pt 1):743-4. PubMed ID: 80674
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmopressin acetate (DDAVP). Good news.
    Kasper CK
    JAMA; 1984 May; 251(19):2564-5. PubMed ID: 6609247
    [No Abstract]   [Full Text] [Related]  

  • 18. Common bleeding disorders: a potential catastrophe for the trauma victim. Therapeutic recommendations for the treatment of von Willebrand's disease.
    Slam K; Zyromski N; Nowicki P; Serrano P; Purtill MA
    J Trauma; 2008 May; 64(5):1373-5. PubMed ID: 18469664
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L; Boggio L; Green D
    Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
    [No Abstract]   [Full Text] [Related]  

  • 20. [Response to DDAVP in von Willebrand disease type II C].
    Batllé Fonrodona J; López Fernández MF; Martín González R; Fernández Villamor A; López Borrasca A; Lasierra Cirujeda J
    Sangre (Barc); 1985; 30(2):181-4. PubMed ID: 3925573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.